2024-05-08 14:20:08 ET
Immunic, Inc. (IMUX)
Q1 2024 Earnings Conference Call
May 08, 2024 08:00 AM ET
Company Participants
Jessica Breu - Vice President, Investor Relations & Communications
Daniel Vitt - Chief Executive Officer, President & Director
Glenn Whaley - Chief Financial Officer
Conference Call Participants
Matt Kaplan - Ladenburg Thalmann
Jun-Goo Kwak - Piper Sandler
Mayank Mamtani - B. Riley
Tom Smith - Leerink Partners
Presentation
Jessica Breu
Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, Investor Relations and Communications here at Immunic. I will also be the moderator today.
Speaking on the call are Dr. Daniel Vitt, our Chief Executive Officer and President; as well as Glenn Whaley, our Chief Financial Officer. Please note that all participants will be in listen-only mode, and this event is being recorded. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]
Before we begin, I would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, estimate or words with a similar meaning, and such statements involve a number of risks and uncertainties that could cause Immunic's actual results to differ materially from those discussed here.
Please note that these forward-looking statements reflect Immunic's opinions only as of the date of this presentation, and it undertakes no obligation to revise or publicly release the result of any revision to these forward-looking statements in light of new information or future events. Please refer to Immunic's SEC filings for a more detailed description of the risk factors that may affect Immunic's results and these forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
Immunic, Inc. (IMUX) Q1 2024 Earnings Call Transcript